Raythatha Jigar 4
4 · Jounce Therapeutics, Inc. · Filed Sep 15, 2021
Insider Transaction Report
Form 4
Raythatha Jigar
Director
Transactions
- Award
Common Stock
2021-09-13+31,400→ 31,400 totalExercise: $6.47Exp: 2031-09-13→ Common Stock (31,400 underlying)
Footnotes (1)
- [F1]The option was granted on September 13, 2021 and will vest in equal quarterly installments during the twelve quarters following the grant date, subject the to Reporting Person's continued service as a director.